Metraipolis › archive › dc_1bca8930246e

Dynamic therapeutic response to osimertinib and immunotherapy in an EGFR L747S and L858R co-mutant NSCLC — Europe PMC PMID:42249563

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42249563
DOI
10.1093/oncolo/oyag227
License (as archived)
solo-consultazione
Archived
2026-11-01T01:02:10.023Z
SHA-256 of the archived text
41ac68bcd7b5fe31dc56b28fc20f225daf52ecd0408d4d36b1c36c57616327e5
Stable URL of this page
https://metraipolis.com/documento/dc_1bca8930246e

How to cite

Dynamic therapeutic response to osimertinib and immunotherapy in an EGFR L747S and L858R co-mutant NSCLC — Europe PMC PMID:42249563 — Europe PMC (en), https://europepmc.org/article/MED/42249563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1bca8930246e (Metraipolis archive dc_1bca8930246e, sha256 41ac68bcd7b5fe31dc56b28fc20f225daf52ecd0408d4d36b1c36c57616327e5)
BibTeX
@misc{dc1bca8930246e,
  title = {Dynamic therapeutic response to osimertinib and immunotherapy in an EGFR L747S and L858R co-mutant NSCLC — Europe PMC PMID:42249563},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42249563},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1bca8930246e; sha256 41ac68bcd7b5fe31dc56b28fc20f225daf52ecd0408d4d36b1c36c57616327e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42249563. Agents can read the archived copy with the MCP tool read_document.